Investment to tackle NHS pressures in Wales

Welsh patients are to benefit from an additional £2.5 million investment in community pharmacy services this winter, the Welsh Government has revealed.

The funding announced today will be part of a package of measures to help the NHS recover from the ongoing coronavirus pandemic, alleviate waiting times and reduce winter pressures.

The one-off community pharmacy monies aim to enhance access to free NHS treatment and advice across Wales for patients with a range of common ailments including  sore throat/tonsillitis, conjunctivitis, and diarrhoea. Utilising the clinical skills of pharmacists in the community will form a key part of the Welsh Government’s plans to reduce pressures on GPs and other NHS services this winter.

Commenting on the announcement, Elen Jones, RPS Director for Wales said: “We are delighted that the Welsh Government continue to recognise the value of pharmacists in patient care and we welcome this additional investment and support for Community Pharmacy teams across Wales.

"We fully support the approach to enhancing patient access to primary health care by further utilising the skills and knowledge of community pharmacists. We are very pleased that these additional monies will support the flexibility and resilience of community pharmacy teams in continuing to deliver services throughout the demanding winter months.  

"Community pharmacy will continue play a pivotal role in supporting patients this winter. As always, it is vital that patients are fully informed about the range of health services available to them so they can make the right choice in accessing the right service at the right time."

Read more RPS Wales news